Longitudinal Observation of Changes in Pain Sensitivity during Opioid Tapering in Patients with Chronic Low-Back Pain

Pain Medicine

Volumn 12, Issue 12, 2011, Pages 1720-1726

  Wang, Haili ^a   Akbar, Michael ^a   Weinsheimer, Nina ^a   Gantz, Simone ^a   Schiltenwolf, Marcus ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Chronic Low back Pain; Opioid Tapering; Pain Sensitivity; Quantitative Sensory Testing

Indexed keywords

ANALGESIC AGENT; DOXEPIN; FENTANYL; HYDROMORPHONE; METHANE; MORPHINE; OPIATE; OXYCODONE; TILIDINE; TRAMADOL;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HEAT SENSATION; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOCICEPTION; PAIN THRESHOLD; SIDE EFFECT; SINGLE BLIND PROCEDURE; SLEEP DISORDER; SWEATING; TREATMENT DURATION; WEAKNESS;

EID: 83655161392     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01276.x     Document Type: Article

References (29)

1. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 2004;112(3):372-80.
2. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ 2006;174(11):1589-94.
3. Martell BA, O'Connor PG, Kerns RD, etal. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146(2):116-27.
4. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: Systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005;7(5):R1046-51.
5. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003;106(1-2):49-57.
6. Compton P, Athanasos P, Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: A preliminary study. J Pain 2003;4(9):511-9.
7. Celerier E, Rivat C, Jun Y, etal. Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology 2000;92(2):465-72.
8. Rivat C, Laulin JP, Corcuff JB, etal. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: Prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology 2002;96(2):381-91.
9. Koppert W, Sittl R, Scheuber K, etal. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 2003;99(1):152-9.
10. Chou R, Fanciullo GJ, Fine PG, etal. Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10(2):131-46.
11. Gartner CM, Schiltenwolf M. [Limited efficacy of opioids in chronic musculoskeletal pain]. Schmerz 2004;18(6):506-14.
12. Younger J, Barelka P, Carrol I, etal. Reduced cold pain tolerance in chronic pain patients following opioid detoxification. Pain Med 2008;9(8):1158-63.
13. Prosser JM, Steinfeld M, Cohen LJ, etal. Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance. Drug Alcohol Depend 2008;95(3):237-44.
14. Fillingim RB, Doleys DM, Edwards RR, Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine (Phila Pa 1976) 2003;28(2):143-50.
15. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992;50(2):133-49.
16. Reznikov I, Pud D, Eisenberg E. Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. Br J Clin Pharmacol 2005;60(3):311-8.
17. Lawlor PG, Turner KS, Hanson J, Bruera ED. Dose ratio between morphine and methadone in patients with cancer pain: A retrospective study. Cancer 1998;82(6):1167-73.
18. Raghavendra V, Rutkowski MD, DeLeo JA. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002;22(22):9980-9.
19. Raghavendra V, Tanga FY, DeLeo JA. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 2004;29(2):327-34.
20. Bie B, Pan ZZ. Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors. J Neurosci 2003;23(19):7262-8.
21. Graven-Nielsen T, Arendt-Nielsen L. Peripheral and central sensitization in musculoskeletal pain disorders: An experimental approach. Curr Rheumatol Rep 2002;4(4):313-21.
22. Deyo RA, Mirza SK, Turner JA, Martin BI. Overtreating chronic back pain: Time to back off? J Am Board Fam Med 2009;22(1):62-8.
23. Deshpande A, Furlan A, Mailis-Gagnon A, Atlas S, Turk D. Opioids for chronic low-back pain. Cochrane Database Syst Rev 2007;(3):CD004959.
24. Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain 2002;100(3):213-7.
25. Meh D, Denislic M. Quantitative assessment of thermal and pain sensitivity. J Neurol Sci 1994;127(2):164-9.
26. Hirosawa I, Dodo H, Hosokawa M, etal. Physiological variations of warm and cool sense with shift of environmental temperature. Int J Neurosci 1984;24(3-4):281-8.
27. Levine FM, De Simone LL. The effects of experimenter gender on pain report in male and female subjects. Pain 1991;44(1):69-72.
28. Feine JS, Bushnell MC, Miron D, Duncan GH. Sex differences in the perception of noxious heat stimuli. Pain 1991;44(3):255-62.
29. Kelly KG, Cook T, Backonja MM. Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing. Muscle Nerve 2005;32(2):179-84.